Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Muracciole

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1994
[Association of radiation- and fotemustine-therapy in the management of brain metastases from non-small-cell cancers of the lung]T Pignon, P Astoul, S Ruggieri, et al.
Journal of Neurosurgery|January 10, 2002
Long-term outcome after gamma knife surgery for secondary trigeminal neuralgiaJ Régis, P Metellus, H Dufour, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 23, 2024
[Characteristics of radiotherapy for adolescents and young adults]L Ollivier, A Laprie, E Jouglar, et al.
The Journal of Nutrition, Health & Aging|February 1, 2020
HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate CancerA L Couderc, X Muracciole, E Nouguerede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapyO L Chinot, S Honore, H Dufour, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 2005
Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1F Fina, X Muracciole, P Rocchi, et al.
Oncogene|July 20, 2007
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cellsC Berenguer, F Boudouresque, C Dussert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2005
Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiformeM Barrié, C Couprie, H Dufour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patientsJ P Droz, X Muracciole, N Mottet, et al.
Anticancer Research|November 20, 2001
Chemotherapy and concomitant irradiation in inflammatory breast cancerN Tubiana-Mathieu, C Lejeune, P Bonnier, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1994
[Association of radiation- and fotemustine-therapy in the management of brain metastases from non-small-cell cancers of the lung]T Pignon, P Astoul, S Ruggieri, et al.
Journal of Neurosurgery|January 10, 2002
Long-term outcome after gamma knife surgery for secondary trigeminal neuralgiaJ Régis, P Metellus, H Dufour, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 23, 2024
[Characteristics of radiotherapy for adolescents and young adults]L Ollivier, A Laprie, E Jouglar, et al.
The Journal of Nutrition, Health & Aging|February 1, 2020
HoSAGE: Sarcopenia in Older Patients before and after Treatment with Androgen Deprivation Therapy and Radiotherapy for Prostate CancerA L Couderc, X Muracciole, E Nouguerede, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapyO L Chinot, S Honore, H Dufour, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 2005
Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1F Fina, X Muracciole, P Rocchi, et al.
Oncogene|July 20, 2007
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cellsC Berenguer, F Boudouresque, C Dussert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2005
Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiformeM Barrié, C Couprie, H Dufour, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 26, 2003
Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patientsJ P Droz, X Muracciole, N Mottet, et al.
Anticancer Research|November 20, 2001
Chemotherapy and concomitant irradiation in inflammatory breast cancerN Tubiana-Mathieu, C Lejeune, P Bonnier, et al.
Pageof 3